(Q37988796)

26 August 2017

title

Cardiovascular autonomic neuropathies as complications of diabetes mellitus (English)

1 reference

26 August 2017

1 reference

Michael Kuehl

1

1 reference

26 August 2017

Martin J Stevens

series ordinal

2

1 reference

26 August 2017

publication date

28 February 2012

1 reference

Nature Reviews Endocrinology

26 August 2017

published in

1 reference

26 August 2017

volume

8

1 reference

26 August 2017

issue

7

1 reference

26 August 2017

page(s)

405-416

1 reference

Projecting the future diabetes population size and related costs for the U.S.

26 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.21

Glycemic control, complications, and death in older diabetic patients: the diabetes and aging study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.21

Diabetic Neuropathies: Update on Definitions, Diagnostic Criteria, Estimation of Severity, and Treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.21

Diabetic somatic neuropathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.21

Prevalence of diabetic peripheral neuropathy and its relation to glycaemic control and potential risk factors: the EURODIAB IDDM Complications Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.21

Effects of prior intensive insulin therapy on cardiac autonomic nervous system function in type 1 diabetes mellitus: the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications study (DCCT/EDIC).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.21

Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.21

Effect of a multifactorial intervention on mortality in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.21

Alpha-lipoic Acid and diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.21

Microvascular reactivity and inflammatory cytokines in painful and painless peripheral diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.21

How does glucose generate oxidative stress in peripheral nerve?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.21

Role of nitrosative stress and peroxynitrite in the pathogenesis of diabetic complications. Emerging new therapeutical strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.21

Diabetic autonomic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.21

Diabetic neuropathy: mechanisms to management

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.21

Cardiac autonomic diabetic neuropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.21

Autonomic imbalance: prophet of doom or scope for hope?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.21

Autoantibodies to autonomic nerves associated with cardiac and peripheral autonomic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.21

Prevalence of autoantibodies to autonomic nervous tissue structures in Type 1 diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.21

Essential fatty acids in the management of impaired nerve function in diabetes

21 January 2018

2 references

https://api.crossref.org/works/10.1038%2FNRENDO.2012.21

21 January 2018

12 December 2020

Nerve growth factor and diabetic neuropathy

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.21

Autonomic neural dysfunction in recently diagnosed diabetic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.21

Progression of cardiovascular autonomic dysfunction in patients with type 2 diabetes: a 7-year follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.21

Cardiac autonomic neuropathy in diabetic patients: influence of diabetes duration, obesity, and microangiopathic complications--the French multicenter study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.21

Risk factors for cardiac autonomic neuropathy in type 1 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.21

Sympathetic dysfunction in type 1 diabetes: association with impaired myocardial blood flow reserve and diastolic dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.21

Heart rate variability: standards of measurement, physiological interpretation and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.21

Autonomic symptoms and diabetic neuropathy: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.21

Software for advanced HRV analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.21

Power spectrum analysis of heart rate variability to assess the changes in sympathovagal balance during graded orthostatic tilt

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.21

Beat to beat variability in cardiovascular variables: noise or music?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.21

Diabetic cardiovascular autonomic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.21

Time and frequency domain estimates of spontaneous baroreflex sensitivity provide early detection of autonomic dysfunction in diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.21

Impaired autonomic function is associated with increased mortality, especially in subjects with diabetes, hypertension, or a history of cardiovascular disease: the Hoorn Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.21

Evidence for regional catecholamine uptake and storage sites in the transplanted human heart by positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.21

Scintigraphic assessment of regionalized defects in myocardial sympathetic innervation and blood flow regulation in diabetic patients with autonomic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.21

Assessment of cardiac sympathetic nerve integrity with positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.21

Prevalence and significance of left ventricular filling abnormalities determined by Doppler echocardiography in young type I (insulin-dependent) diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.21

Left ventricular diastolic dysfunction as an early manifestation of diabetic cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.21

Paradoxical increase in ventricular torsion and systolic torsion rate in type I diabetic patients under tight glycemic control.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.21

Increased left ventricular torsion in uncomplicated type 1 diabetic patients: the role of coronary microvascular function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.21

Abnormal left ventricular torsion and cardiac autonomic dysfunction in subjects with type 1 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.21

Decreased myocardial perfusion reserve in diabetic autonomic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.21

A randomized trial of the impact of strict glycaemic control on myocardial diastolic function and perfusion reserve: a report from the DADD (Diabetes mellitus And Diastolic Dysfunction) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.21

Relationship between longitudinal and radial contractility in subclinical diabetic heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.21

Effects of streptozotocin diabetes on the noradrenergic innervation of the rat heart: a longitudinal histofluorescence and neurochemical study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.21

cAMP-dependent phosphorylation of the nuclear encoded 18-kDa (IP) subunit of respiratory complex I and activation of the complex in serum-starved mouse fibroblast cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.21

alpha- and beta-adrenergic pathways differentially regulate cell type-specific apoptosis in rat cardiac myocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.21

Norepinephrine stimulates apoptosis in adult rat ventricular myocytes by activation of the beta-adrenergic pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.21

Role of changes in cardiac metabolism in development of diabetic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.21

Increased myocardial fatty acid metabolism in patients with type 1 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.21

Controversies on the sensitivity of the diabetic heart to ischemic injury: the sensitivity of the diabetic heart to ischemic injury is decreased

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.21

Putative function and physiological relevance of the mitochondrial uncoupling protein-3: involvement in fatty acid metabolism?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.21

Acute effect of fatty acids on metabolism and mitochondrial coupling in skeletal muscle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.21

Diabetic cardiomyopathy: fact or fiction?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.21

Medical therapy can improve the biological properties of the chronically failing heart. A new era in the treatment of heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.21

Cardiac manifestations in oxidative phosphorylation disorders of childhood

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.21

Abnormal cardiac and skeletal muscle energy metabolism in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.21

Treatment of arrhythmias by intracardiac electrical stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.21

Effects of chronic beta-adrenergic blockade on the left ventricular and cardiocyte abnormalities of chronic canine mitral regurgitation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.21

Effect of denervation on the expression of two glucose transporter isoforms in rat hindlimb muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.21

Chronic catecholamine depletion switches myocardium from carbohydrate to lipid utilisation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.21

Stress testing in patients with diabetes mellitus: diagnostic and prognostic value

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.21

Use of heart rate reserve and rating of perceived exertion to prescribe exercise intensity in diabetic autonomic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.21

The sympathetic nervous system in diabetic neuropathy. A clinical and pathological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.21

Cardiac autonomic neuropathy in diabetes: a clinical perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.21

Consensus statement on the definition of orthostatic hypotension, pure autonomic failure, and multiple system atrophy. The Consensus Committee of the American Autonomic Society and the American Academy of Neurology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.21

Effects of cardiac autonomic dysfunction on mortality risk in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.21

The association between cardiovascular autonomic neuropathy and mortality in individuals with diabetes: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.21

Microalbuminuria and cardiovascular autonomic dysfunction are independently associated with cardiovascular mortality: evidence for distinct pathways: the Hoorn Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.21

Prediction of mortality using measures of cardiac autonomic dysfunction in the diabetic and nondiabetic population: the MONICA/KORA Augsburg Cohort Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.21

Decreased heart rate variability and its association with increased mortality after acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.21

Heart failure management using implantable devices for ventricular resynchronization: Comparison of Medical Therapy, Pacing, and Defibrillation in Chronic Heart Failure (COMPANION) trial. COMPANION Steering Committee and COMPANION Clinical Investiga

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.21

Continuous 24-hour assessment of the neural regulation of systemic arterial pressure and RR variabilities in ambulant subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.21

Exertional myocardial ischemia in diabetes: a quantitative analysis of anginal perceptual threshold and the influence of autonomic function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.21

Predictive value of cardiac autonomic neuropathy in diabetic patients with or without silent myocardial ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.21

Detection of silent myocardial ischemia in asymptomatic diabetic subjects: the DIAD study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.21

Differences in autonomic nerve function in patients with silent and symptomatic myocardial ischaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.21

Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.21

Metabolic memory in diabetes--focus on insulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.21

A 6-month, randomized, double-masked, placebo-controlled study evaluating the effects of the protein kinase C-beta inhibitor ruboxistaurin on skin microvascular blood flow and other measures of diabetic peripheral neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.21

Long-term glycemic control influences the long-lasting effect of hyperglycemia on endothelial function in type 1 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.21

Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.21

The association among autonomic nervous system function, incident diabetes, and intervention arm in the Diabetes Prevention Program

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.21

Effect of quinapril or losartan alone and in combination on left ventricular systolic and diastolic functions in asymptomatic patients with diabetic autonomic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.21

Blood pressure and cardiac autonomic nervous system in obese type 2 diabetic patients: effect of metformin administration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.21

Autonomic peripheral neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.21

Cardiovascular autonomic neuropathy due to diabetes mellitus: clinical manifestations, consequences, and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.21

Evidence for pre- to postsynaptic mismatch of the cardiac sympathetic nervous system in ischemic congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.21

Effects of treatment with the antioxidant alpha-lipoic acid on cardiac autonomic neuropathy in NIDDM patients. A 4-month randomized controlled multicenter trial (DEKAN Study). Deutsche Kardiale Autonome Neuropathie

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.21

A peroxynitrite decomposition catalyst counteracts sensory neuropathy in streptozotocin-diabetic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.21

Nitrosative stress and peripheral diabetic neuropathy in leptin-deficient (ob/ob) mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.21

Amelioration of neurological and biochemical deficits by peroxynitrite decomposition catalysts in experimental diabetic neuropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.21

Epicatechin blocks pro-nerve growth factor (proNGF)-mediated retinal neurodegeneration via inhibition of p75 neurotrophin receptor expression in a rat model of diabetes [corrected].

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.21

The therapeutic potential of poly(ADP-ribose) polymerase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.21

Inhibition of GAPDH activity by poly(ADP-ribose) polymerase activates three major pathways of hyperglycemic damage in endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.21

PARP inhibition or gene deficiency counteracts intraepidermal nerve fiber loss and neuropathic pain in advanced diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.21

New therapeutic and biomarker discovery for peripheral diabetic neuropathy: PARP inhibitor, nitrotyrosine, and tumor necrosis factor-{alpha}

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.21

Glucagon-like peptide-1-based therapies and cardiovascular disease: looking beyond glycaemic control.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.21

Effects of incretin hormones on beta-cell mass and function, body weight, and hepatic and myocardial function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.21

Glucagon-like peptide 1 receptor stimulation reverses key deficits in distinct rodent models of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.21

Glucagon-like peptide-1 inhibits LPS-induced IL-1beta production in cultured rat astrocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.21

Tissue-specific expression of the human receptor for glucagon-like peptide-I: brain, heart and pancreatic forms have the same deduced amino acid sequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.21

A novel neurotrophic property of glucagon-like peptide 1: a promoter of nerve growth factor-mediated differentiation in PC12 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.21

Differentiating effects of the glucagon-like peptide-1 analogue exendin-4 in a human neuronal cell model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.21

Anti-apoptotic action of exendin-4 in INS-1 beta cells: comparative protein pattern analysis of isolated mitochondria

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.21

Glucagon-like peptide-1 prevents beta cell glucolipotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.21

Evidence of GLP-1-mediated neuroprotection in an animal model of pyridoxine-induced peripheral sensory neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.21

Effects of glucagon-like peptide-1, yohimbine, and nitrergic modulation on sympathetic and parasympathetic activity in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.21

Impaired subendocardial contractile myofiber function in asymptomatic aged humans, as detected using MRI

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.21

Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.21

Cardiovascular autonomic neuropathy in diabetes: clinical impact, assessment, diagnosis, and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.21

The effect of intensive diabetes therapy on measures of autonomic nervous system function in the Diabetes Control and Complications Trial (DCCT)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.21

Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: the Steno type 2 randomised study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.21

The role of poly(ADP-ribose) polymerase activation in the development of myocardial and endothelial dysfunction in diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.21

Autoantibodies against sympathetic ganglia and evidence of cardiac sympathetic dysinnervation in newly diagnosed and long-term IDDM patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.21

Neuropathy profile of diabetic patients in a pancreas transplantation program

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.21

Left ventricular dysfunction in normotensive Type 1 diabetic patients: the impact of autonomic neuropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.21

Assessment of cardiovascular autonomic function: age-related normal ranges and reproducibility of spectral analysis, vector analysis, and standard tests of heart rate variation and blood pressure responses

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.21

Determination of baroreflex sensitivity during the modified Oxford maneuver by trigonometric regressive spectral analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.21

Evidence of defective cardiovascular regulation in insulin-dependent diabetic patients without clinical autonomic dysfunction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.21

Early autonomic dysfunction in type 1 diabetes: a reversible disorder?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.21

Regional in vivo and in vitro characterization of autonomic innervation in cardiomyopathic human heart

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.21

Regression and progression of cardiac sympathetic dysinnervation complicating diabetes: An assessment by C-11 hydroxyephedrine and positron emission tomography

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.21

Cardiac sympathetic dysinnervation in diabetes: implications for enhanced cardiovascular risk

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.21

MRI assessment of LV relaxation by untwisting rate: a new isovolumic phase measure of tau.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.21

Relationship Between Coronary Microvascular Dysfunction and Cardiac Energetics Impairment in Type 1 Diabetes Mellitus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.21

Antioxidants and myocardial contractility: illuminating the "Dark Side" of beta-adrenergic receptor activation?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.21

Delineation of myocardial oxygen utilization with carbon-11-labeled acetate

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.21

Myocardial cell death in human diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.21

Effect of amlodipine on morbidity and mortality in severe chronic heart failure. Prospective Randomized Amlodipine Survival Evaluation Study Group

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.21

Radiolabeled acetate as a tracer of myocardial tricarboxylic acid cycle flux

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.21

The role of propranolol in the treatment of acute myocardial infarction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.21

Relative effects of alpha 1-adrenoceptor blockade, converting enzyme inhibitor therapy, and angiotensin II subtype 1 receptor blockade on ventricular remodeling in the dog

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.21

Effect of denervation or unweighting on GLUT-4 protein in rat soleus muscle

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.21

Inhibition of glycolysis in the denervated dog heart

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.21

Autonomic neuropathy and survival in diabetes mellitus: effects of pancreas transplantation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.21

Mortality in diabetic patients with cardiovascular autonomic neuropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.21

Assessment of cardiovascular effects in diabetic autonomic neuropathy and prognostic implications

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.21

Why does diabetic autonomic neuropathy predict IDDM mortality? An analysis from the Pittsburgh Epidemiology of Diabetes Complications Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.21

Prevalence of QT prolongation in a type 1 diabetic population and its association with autonomic neuropathy. The Neuropathy Study Group of the Italian Society for the Study of Diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.21

The relation between QTc interval prolongation and diabetic complications. The EURODIAB IDDM Complication Study Group

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.21

Cardiac autonomic neuropathy in diabetes mellitus: prevalence, risk factors and utility of corrected QT interval in the ECG for its diagnosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.21

Is abnormal iodine-123-MIBG kinetics associated with left ventricular dysfunction in patients with diabetes mellitus?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.21

Relationship between the circadian rhythms of blood pressure and sympathovagal balance in diabetic autonomic neuropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.21

Increase in nocturnal blood pressure and progression to microalbuminuria in diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.21

The effects of intensive glycemic control on neuropathy in the VA cooperative study on type II diabetes mellitus (VA CSDM)

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.21

Effect of chronic quinapril administration on heart rate variability in patients with diabetic autonomic neuropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.21

Long-term effect of epalrestat on cardiac autonomic neuropathy in subjects with non-insulin dependent diabetes mellitus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.21

Consensus statement: Report and recommendations of the San Antonio conference on diabetic neuropathy. American Diabetes Association American Academy of Neurology

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.21

Effect of angiotensin-converting enzyme inhibitors on the power spectrum of heart rate variability in post-myocardial infarction patients.

31 March 2020

1 reference

12 December 2020

Progression of diabetic autonomic neuropathy over a decade in insulin-dependent diabetics

1 reference

12 December 2020

Potential deleterious effects of inotropic agents in the therapy of chronic heart failure

1 reference

12 December 2020

Insulin resistance of denervated rat muscle: a model for impaired receptor-function coupling.

1 reference

12 December 2020

The influence of autonomic neuropathy on mortality in insulin-dependent diabetes.

1 reference

12 December 2020

Myocardial dysfunction and adrenergic innervation in patients with Type 1 diabetes mellitus

1 reference

12 December 2020

Autonomic nervous system and sudden cardiac death. Experimental basis and clinical observations for post-myocardial infarction risk stratification

1 reference

12 December 2020

Elevation of serum and ventricular norepinephrine content in the diabetic rat

1 reference

12 December 2020

Myocardial kinetics of carbon-11-meta-hydroxyephedrine: retention mechanisms and effects of norepinephrine

1 reference

12 December 2020

The natural history of diabetic autonomic neuropathy

1 reference

12 December 2020

Assessment: Clinical autonomic testing report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology

1 reference

12 December 2020

Epinephrine increases ATP production in hearts by preferentially increasing glucose metabolism

1 reference

12 December 2020

Prevalence and clinical correlates of cardiovascular autonomic and peripheral diabetic neuropathy in patients attending diabetes centers. The Diacan Multicenter Study Group

1 reference

12 December 2020

Insulin action in denervated rat hemidiaphragms. Decreased hormonal stimulation of glycogen synthesis involves both glycogen synthase and glucose transport

1 reference

12 December 2020

Energy provision from glycogen, glucose, and fatty acids on adrenergic stimulation of isolated working rat hearts

1 reference

12 December 2020

Mechanistic and clinical rationales for using beta-blockers in heart failure.

1 reference

12 December 2020

Autonomic reflex dysfunction in patients presenting for elective surgery is associated with hypotension after anesthesia induction.

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRENDO.2012.21

1 reference

26 August 2017

1 reference